Nutex Health is trading up 7.87% at $195.66 alongside a strong broader-market rally on November 4, 2026.

  • The S&P 500, Nasdaq Composite, and Dow Jones were all higher by more than 1.7%. Easing election uncertainty and improving risk appetite offer the clearest available context; no new company-specific catalyst is confirmed.
  • Nutex Health’s Q3 results are scheduled for November 5 after market close, and the earnings preview does not establish that anticipation caused today’s gain.